241 related articles for article (PubMed ID: 25604729)
21. Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer.
Matsuura K; Kimura T; Kashiwado K; Fujita K; Akagi Y; Yuki S; Murakami Y; Wadasaki K; Monzen Y; Ito A; Kagemoto M; Mori M; Ito K; Nagata Y
Int J Clin Oncol; 2009 Oct; 14(5):408-15. PubMed ID: 19856048
[TBL] [Abstract][Full Text] [Related]
22. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans.
Stuschke M; Kaiser A; Pöttgen C; Lübcke W; Farr J
Radiother Oncol; 2012 Jul; 104(1):45-51. PubMed ID: 22560714
[TBL] [Abstract][Full Text] [Related]
23. [Involved-field three-dimensional conformal radiation treatment for stage III non-small-cell lung].
Yu JM; Sun XD; Li MH; Zhang JD; Yao CP; Liu S; Zhang Z
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):526-9. PubMed ID: 17147119
[TBL] [Abstract][Full Text] [Related]
24. Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer.
Ohno T; Oshiro Y; Mizumoto M; Numajiri H; Ishikawa H; Okumura T; Terunuma T; Sakae T; Sakurai H
J Radiat Res; 2015 Jan; 56(1):128-33. PubMed ID: 25368341
[TBL] [Abstract][Full Text] [Related]
25. Involved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF).
Li R; Yu L; Lin S; Wang L; Dong X; Yu L; Li W; Li B
Radiat Oncol; 2016 Sep; 11(1):124. PubMed ID: 27655339
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer.
Abe T; Iino M; Saito S; Aoshika T; Ryuno Y; Ohta T; Igari M; Hirai R; Kumazaki Y; Miura Y; Kaira K; Kagamu H; Noda SE; Kato S
J Radiat Res; 2021 Sep; 62(5):894-900. PubMed ID: 34260719
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of Pencil Beam Scanned Intensity Modulated Proton Therapy in Breath-hold for Locally Advanced Non-Small Cell Lung Cancer.
Gorgisyan J; Munck Af Rosenschold P; Perrin R; Persson GF; Josipovic M; Belosi MF; Engelholm SA; Weber DC; Lomax AJ
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1121-1128. PubMed ID: 28964587
[TBL] [Abstract][Full Text] [Related]
29. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
30. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located.
Zhao L; Chen M; Ten Haken R; Chetty I; Chapet O; Hayman JA; Kong FM
Radiother Oncol; 2007 Feb; 82(2):153-9. PubMed ID: 17287040
[TBL] [Abstract][Full Text] [Related]
32. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
[No Abstract] [Full Text] [Related]
33. [Lung cancer and elective nodal irradiation: A solved issue?].
Laurans M; Botticella A; Moukasse Y; Lévy A; Le Péchoux C
Cancer Radiother; 2019 Oct; 23(6-7):701-707. PubMed ID: 31501024
[TBL] [Abstract][Full Text] [Related]
34. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
Chi A; Lin LC; Wen S; Yan H; Hsi WC
Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
[TBL] [Abstract][Full Text] [Related]
35. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?
Jeremic B
Radiother Oncol; 2004 May; 71(2):123-5. PubMed ID: 15110444
[No Abstract] [Full Text] [Related]
36. Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC.
Gjyshi O; Xu T; Elhammali A; Boyce-Fappiano D; Chun SG; Gandhi S; Lee P; Chen AB; Lin SH; Chang JY; Tsao A; Gay CM; Zhu XR; Zhang X; Heymach JV; Fossella FV; Lu C; Nguyen QN; Liao Z
J Thorac Oncol; 2021 Feb; 16(2):269-277. PubMed ID: 33198942
[TBL] [Abstract][Full Text] [Related]
37. Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancer.
Nichols RC; Huh SH; Hoppe BS; Henderson RH; Li Z; Flampouri S; D'Agostino HJ; Cury JD; Pham DC; Mendenhall NP
Technol Cancer Res Treat; 2011 Aug; 10(4):317-22. PubMed ID: 21728388
[TBL] [Abstract][Full Text] [Related]
38. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
[TBL] [Abstract][Full Text] [Related]
39. Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO
Troost EGC; Wink KCJ; Roelofs E; Simone CB; Makocki S; Löck S; van Kollenburg P; Dechambre D; Minken AWH; van der Stoep J; Avery S; Jansen N; Solberg T; Bussink J; de Ruysscher D
Br J Radiol; 2020 Mar; 93(1107):20190879. PubMed ID: 31804145
[TBL] [Abstract][Full Text] [Related]
40. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
